Key result
A 6-minute walk test distance ≥300 m protected against mortality in elderly CABG patients (HR 0.34; 95% CI 0.10-0.79), whereas ejection fraction ≥50% was protective only in adults <65 years.
Why the study?
Does the prognostic value of the 6-minute walking test and ejection fraction for mortality differ between adult and elderly patients undergoing cardiac rehabilitation after CABG?
Cohort (n=882)
Does the prognostic value of the 6-minute walking test and ejection fraction for mortality differ between adult and elderly patients undergoing cardiac rehabilitation after CABG?
Hazard Ratio: 0.34 (95% CI 0.1–0.79)
p-value: p=0.033
In patients undergoing cardiac rehabilitation after CABG, ejection fraction is a better predictor of mortality in younger adults (<65 years), whereas functional capacity (6MWT) is a better predictor in the elderly (≥65 years).
Supports age-specific risk stratification after CABG; leaves open whether 6MWT integration improves elderly outcomes.
BACKGROUND: Age-related effects on the ability of 6-min walking test (6MWT) and ejection fraction (EF) to predict mortality in coronary artery bypass grafting (CABG) patients undergoing cardiac rehabilitation (CR) is still debated. DESIGN AND METHODS: In order to verify the role of 6MWT and EF on all-cause mortality in patients undergoing CR following CABG, 882 CABG patients undergoing CR stratified in adults (<65 years) and elderly (≥65 years) were studied. RESULTS: At the admission, EF was 52.6 ± 9.1% in adults and 51.3 ± 8.9% in elderly (p = 0.234, NS) while 6MWT was 343.8 ± 93.5 m in adults and 258.9 ± 95.7 m in elderly (p < 0.001). After 42.9 ± 14.1 months follow up, mortality was 8.2% in adults and 10.9% in elderly (p = 0.176, NS). Cox regression analysis shows that EF ≥ 50% and 6MWT ≥300 m are protective on mortality in all CABG patients before CR. However, EF ≥50% in adults (HR 0.18, 95% CI 0.06-0.49, p < 0.005) but not in elderly (HR 1.16, 95% CI 0.45-3.42, p = 0.354, NS) and 6MWT ≥300 m in elderly (HR 0.34, 95% CI 0.10-0.79, p = 0.033) but not in adults (HR 0.76, 95% CI 0.31-2.12, p = 0.654, NS) exert a protective role on mortality. CONCLUSIONS: Our results indicate that both EF ≥ 50% and 6MWT ≥ 300 m independently protect against mortality in CABG patients before CR. However, their protective role is age dependent. In fact, EF ≥ 50% is protective in adults but not in elderly while 6MWT ≥ 300 m is protective in elderly but not in adult patients.
No takes yet. Share an insight, caveat, or question.
Cacciatore et al. (2011) conducted a cohort in Coronary artery bypass grafting (CABG) undergoing cardiac rehabilitation (n=882). 6-minute walking test (6MWT) ≥300 m vs. 6MWT <300 m was evaluated on all-cause mortality (HR 0.34, 95% CI 0.10-0.79, p=0.033). A 6-minute walk test distance ≥300 m protected against mortality in elderly CABG patients (HR 0.34; 95% CI 0.10-0.79), whereas ejection fraction ≥50% was protective only in adults <65 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: